SOURCE: BIOLASE Technology, Inc.

BIOLASE Technology, Inc.

May 21, 2012 09:00 ET

BIOLASE Changes Ticker Symbol to BIOL

IRVINE, CA--(Marketwire - May 21, 2012) - BIOLASE, Inc. (NASDAQ: BLTI), the World's leading dental laser manufacturer and distributor, today announced that its ticker symbol will change from "BLTI" to "BIOL" on May 29, 2012.

This ticker change aligns BIOLASE's ticker symbol with the Company's recent name change to BIOLASE, Inc.

Federico Pignatelli, Chairman and CEO, commented, "The change in name is synonymous with the profound changes at BIOLASE over the past 19 months since I became CEO, including the Company's successful turnaround and new business model and direction. With the patented Waterlase technology platform, BIOLASE has invented and perfected a new and revolutionary surgical system that offers a truly biological alternative to the conventional approach of invasive surgery on human and animal tissue. Our mission is to bring to fruition, with wide penetration in dentistry and select areas of medicine, the vastly superior advantages of such a novel and effective approach to surgery."

About BIOLASE, Inc.
BIOLASE, Inc., the World's leading Dental Laser Company, is a medical technology company that develops, manufactures and markets dental lasers and also distributes and markets dental imaging equipment; products that are focused on technologies that advance the practice of dentistry and medicine. The Company's laser products incorporate approximately 285 patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. Its imaging products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold more than 19,600 lasers among 16,000 customers. Other products under development address ophthalmology and other medical and consumer markets.

For updates and information on laser and Waterlase dentistry, find BIOLASE at, Twitter at, and YouTube at

This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, and are described in the Company's reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.

Contact Information

  • For further information, please contact:

    Jill Bertotti
    Allen & Caron